ROSEMARIE SCHMANDT to Immunoconjugates
This is a "connection" page, showing publications ROSEMARIE SCHMANDT has written about Immunoconjugates.
Connection Strength
0.068
-
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma. J Natl Cancer Inst. 2009 Sep 02; 101(17):1193-205.
Score: 0.068
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.